BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2006
View Archived Issues
Eltrombopag induces responses in hepatitis C patients with thrombocytopenia
Read More
Pasireotide shows potential in carcinoid tumors, acromegaly, Cushing's disease
Read More
Targeting LOX might help fight aggressive hypoxic tumors
Read More
Innogenetics and IBL Japan enter into license agreement in Alzheimer's field
Read More
Phase II evaluation of SP-01A begins second stage
Read More
Epigenetic therapy shows results in medulloblastoma in vitro experiments
Read More
GSK advances calcilytic compound from NPS collaboration
Read More
Diamyd Medical plans phase III study of Diamyd
Read More
Zonagen changes name to Repros Therapeutics
Read More
Vical's DNA vaccine protects against avian flu in animal studies
Read More
Smallpox drug candidate SIGA-246 enters phase I trials
Read More
Approvable letter for CIP-Isotretinoin
Read More
Enrollment completed in phase III trials of Nexavar in melanoma and liver cancer
Read More
FDA approves SPA for Puricase phase III trials
Read More
SPA agreement for phase III study of DG-031 for heart attack prevention
Read More
CancerVax stockholders approve merger with Micromet
Read More
XTL-2125 studied for chronic hepatitis C in new phase I trial
Read More
Encouraging phase I data for OGX-011 plus chemotherapy in NSCLC
Read More
Biogen Idec to acquire Conforma Therapeutics
Read More
Significant improvements in endpoints in integrated ambrisentan trials analysis
Read More
New higher dose formulations of Diovan HCT approved
Read More
CHMP recommends Seretide dosing for initial maintenance therapy
Read More
European approval for Tygacil
Read More
RotaTeq recommended for approval in Europe
Read More
Bioniche receives fast track designation for Urocidin
Read More
Recent patents impart new therapeutics for respiratory disorders
Read More
Novel agents for obesity and disorders of lipoprotein metabolism patented
Read More
New therapeutics for cancer covered in recent patent literature
Read More
Small alpha5beta1 integrin inhibitor reduces choroidal neovascularization in different animal models
Read More
Novel beta-tryptase inhibitor developed by Mochida
Read More
Novel antiatherothrombotic drug shows promise in preclinical studies
Read More
Preclinical data on antioxidant drugs for AMD reported by Othera
Read More